UA102139C2 - Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin - Google Patents
Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicinInfo
- Publication number
- UA102139C2 UA102139C2 UAA201110131A UAA201110131A UA102139C2 UA 102139 C2 UA102139 C2 UA 102139C2 UA A201110131 A UAA201110131 A UA A201110131A UA A201110131 A UAA201110131 A UA A201110131A UA 102139 C2 UA102139 C2 UA 102139C2
- Authority
- UA
- Ukraine
- Prior art keywords
- fullerens
- unmodified
- treatment
- malignant tumors
- doxorubicin
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for the treatment of malignant tumors with unmodified fullerens Cin combined chemotherapy with anticancer agent doxorubicin, this inhibits the growth of tumor as well as metastases and reduces toxical influence thereof on organism.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201110131A UA102139C2 (en) | 2011-08-16 | 2011-08-16 | Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201110131A UA102139C2 (en) | 2011-08-16 | 2011-08-16 | Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin |
Publications (1)
Publication Number | Publication Date |
---|---|
UA102139C2 true UA102139C2 (en) | 2013-06-10 |
Family
ID=51948977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201110131A UA102139C2 (en) | 2011-08-16 | 2011-08-16 | Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA102139C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11471484B2 (en) | 2011-06-30 | 2022-10-18 | Fathi Moussa | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
-
2011
- 2011-08-16 UA UAA201110131A patent/UA102139C2/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11471484B2 (en) | 2011-06-30 | 2022-10-18 | Fathi Moussa | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4335511A3 (en) | Small molecule trail gene induction by normal and tumor cells as an anticancer therapy | |
WO2014018563A3 (en) | Methods for the treatment of cancer | |
MX2010000465A (en) | Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders. | |
MX2021003858A (en) | Conjugates for treating diseases caused by psma expressing cells. | |
NZ608142A (en) | Amatoxin-conjugates with improved linkers | |
MX343405B (en) | Alpha-emitting complexes. | |
MX343671B (en) | Methods of treating bladder cancer. | |
EP3722810A3 (en) | Molecular profiling of tumors | |
WO2011037643A3 (en) | Compositions and methods for detecting and treating prostate carcinoma | |
MX360404B (en) | Compounds for inhibiting cell proliferation in egfr-driven cancers. | |
MX2013002084A (en) | Biomarkers and methods of treatment. | |
MX344009B (en) | Amatoxin-conjugates with improved linkages. | |
SG10201810928SA (en) | Novel antitumoral use of cabazitaxel | |
MD20160016A2 (en) | Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same | |
MX2013015340A (en) | Compositions and methods for the treatment of cancer. | |
PH12015501088A1 (en) | Dimeric compounds | |
MX2019013776A (en) | Treatment of solid tumors using coenzyme q10. | |
WO2014165782A3 (en) | Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety | |
MX2013002155A (en) | Compounds for treatment of cancer. | |
AU2012240222A8 (en) | Methods of treating central nervous system tumors | |
WO2013081645A3 (en) | Erbb3 mutations in cancer | |
WO2011056566A3 (en) | Compounds and methods for treatment of cancer | |
AU2018244925A1 (en) | Compositions for the treatment of drug-resistant tumors and methods of use thereof | |
WO2012016050A3 (en) | Chemoradiotherapy for kras-mutant colorectal cancer | |
UA102139C2 (en) | Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin |